Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods

Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Vicente Estrada(Instituto de Salud Carlos III), Giulio Maria Corbelli(Associazione Italiana Vulvodinia Onlus), Simon Collins(Ghent University Hospital), Fiona Lampe(University College London), Pietro Vernazza(University of Zurich), Matthew Weait(University of St.Gallen), Jan van Lunzen(Universidade Federal de São Paulo), Alison Rodger(Royal Free London NHS Foundation Trust), Andrew Phillips(Wake Forest University), Tina Bruun(University of Copenhagen)
BMC Public Health
April 20, 2012
10.1186/1471-2458-12-296
Cited by 34

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2010|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987